Use of albumin in three French university hospitals: Is prescription monitoring still useful in 2004?

Pharmacoepidemiology and Drug Safety

Volumn 16, Issue 1, 2007, Pages 79-85

  Pradel, Vincent ^a   Tardieu, Sophie ^a,b   Micallef, Joëlle ^a,b   Signoret, Anne ^a   Villano, Philippe ^a   Gauthier, Laurence ^a   Vanelle, Patrice ^a   Blin, Olivier ^a,b   Reynier, J P ^c   Bouvenot, G ^c   Balansard, G ^b   Bongrand, M C ^b   Braguer, D ^b   Briand, C ^b   Guedj, M ^b   Harle, J R ^b   Legre R ^b   Maldonado, J ^b   Jean Pastor, M J ^b   Minetti, V ^b   Penot Ragon, C ^b   Gensollen, S ^b   Sale, N ^b   Thirion, X ^b   Timon David, P ^b   Vanelle, P ^b   Villani, P ^b   Ausias, N ^c   Botta Frindlund, D ^c   Camboulives, J ^c   Gouin, F ^c   Lagier, P ^c   Lefevre, P ^c   Simeoni U ^c   Viard, L ^c   Vincentelli, J ^c   Amrani, A ^c   Bosq, I ^c   Bouvenot, J ^c   Bru, B ^c   Carl, F ^c   Coureau, B ^c   Cournede, A ^c   Felix, D ^c   Lucena Morais, P ^c   Ohana, P ^c   Wong, S ^c   more..

^a ASSISTANCE PUBLIQUE HÔPITAUX DE MARSEILLE   (France)

^b Pharmacoepidemiology Commission   (France)

^c NONE

Author keywords

Albumin; Drug utilization study; Hospital

Indexed keywords

ALBUMIN;

ADOLESCENT; ADULT; AGED; ARTICLE; ASCITES; CHILD; CONTROLLED STUDY; DATA ANALYSIS; DRUG FORMULATION; DRUG INDICATION; DRUG MONITORING; DRUG USE; FRANCE; HEPATORENAL SYNDROME; HUMAN; HYPOALBUMINEMIA; INFANT; MAJOR CLINICAL STUDY; PATIENT SELECTION; PLASMAPHERESIS; PRESCRIPTION; PRIORITY JOURNAL; UNIVERSITY HOSPITAL; UNSPECIFIED SIDE EFFECT;

ADOLESCENT; ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; ALBUMINS; CHILD; CHILD, PRESCHOOL; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG MONITORING; FRANCE; HOSPITAL UNITS; HOSPITALS, UNIVERSITY; HUMANS; HYPOALBUMINEMIA; HYPOVOLEMIA; INFANT; INFANT, NEWBORN; INPATIENTS; MIDDLE AGED; NEPHROTIC SYNDROME; PRESCRIPTIONS, DRUG; REPRODUCIBILITY OF RESULTS; TREATMENT OUTCOME;

EID: 33846468341     PISSN: 10538569     EISSN: 10991557     Source Type: Journal    
DOI: 10.1002/pds.1328     Document Type: Article

References (21)

1. Cochrane Injuries Group. Albumin reviewers: human albumin administration in critically ill patients: a systematic review of randomised controlled trials. Br Med J 1998; 317: 235-240.
2. Allison SP, Lobo DN. Debate: albumin administration should not be avoided. Crit Care 2000; 4(3): 147-150.
3. Wilkes MM, Navickis RJ. Patient survival after human albumin administration. A meta-analysis of randomized, controlled trials. Ann Intern Med 2001; 135(3): 149-164.
4. Cook D, Guyatt G. Colloid use for fluid resuscitation: evidence and spin. Ann Intern Med 2001; 135(3): 205-208.
5. Gibney EM. Albumin meta-analysis. Ann Intern Med 2001135(11): 1008-1009.
6. Finfer S, Bellomo R, Boyce N, French J, Myburgh J, Norton R, SAFE Study Investigators. A comparison of albumin and saline for fluid resuscitation in the intensive care unit. N Engl J Med 2004; 350(22): 2247-2256.
7. The Albumin Reviewers (Alderson P, Bunn F, Lefebvre C, Li Wan Po A, Li L, Roberts I, Schierhout G). Human albumin solution for resuscitation and volume expansion in critically ill patients. Cochrane Database Syst Rev 2004; 4: CD001208.
8. Aramwit P, Kasettratat N. Evaluation of serum albumin utilization in inpatient at a private hospital in Bangkok. Yakugaku Zasshi 2004; 124(9): 631-634.
9. Tanzi M, Gardner M, Megellas M, Lucio S, Restino M. Evaluation of the appropriate use of albumin in adult and pediatric patients. Am J Health Syst Pharm 2003; 60(13): 1330-1335.
10. Vargas E, de Miguel V, Portoles A, et al. Use of albumin in two Spanish university hospitals. Eur J Clin Pharmacol 1997; 52(6): 465-470.
11. Debrix I, Combeau D, Stephan F, Benomar A, Becker A. Clinical practice guidelines for the use of albumin: results of a drug use evaluation in a Paris hospital. Tenon Hospital Paris. Pharm World Sci 1999; 21(1): 11-16.
12. von Hoegen I, Waller C. Safety of human albumin based on spontaneously reported serious adverse events. Crit Care Med 2001; 29(5): 994-996.
13. Nascht S, van Leeuwen SJ, de Jong R, Hekster YA. Use of albumin in intensive care Unit patients-is continuous quality assessment necessary? J Clin Pharm Ther 1998; 23(3): 179-183.
14. Massachusetts General Hospital. Albumin Utilization Guidelines [cited 2005 Jan 17]. Available from: http://www.mgh.harvard.edu/labmed/lab/bts/ Albumin%20Utilization%20Guidelines.pdf/.
15. SFAR (Société Française d'Anesthésie et de Réanimation). Remplissage vasculaire au cours des hypovol é mies relatives ou absolues. [Vascular filling in relative or absolute hypovolemia] Ann Fr Anesth Reanim 1997; 16(8): fi8-14.
16. Akcicek F, Yalniz T, Basci A, Ok E, Mees EJ. Diuretic effect of furosemide in patients with nephrotic syndrome: is it potentiated by intravenous albumin? Br Med J 1995; 310(6973): 162-163.
17. Eadington DW, Plant WD, Winney RJ. Albumin in the nephrotic syndrome. Br Med J 1995; 310(6990): 1333.
18. Dorhout Mees EJ. Does it make sense to administer albumin to the patient with nephrotic oedema? Nephrol Dial Transplant 1996; 11(7): 1224-1226.
19. Elwell RJ, Spencer AP, Eisele G. Combined furosemide and human albumin treatment for diuretic-resistant edema. Ann Pharmacother 2003; 37(5): 695-700.
20. Société Française d'Anesthésie et de Réanimation (SFAR). Conférence de consensus sur l'utilization des solutions d'albumine humaine en anesthésie-réanimation chirurgicale chez l'adulte [Consensus meeting on human albumin solutions utilization in surgical anesthesia and intensive care]. [updated 1995 Dec, cited 2005 Jan 17] Available from: http://www.sfar.-org/albumineconsensus.html/.
21. Roberts I, Bunn F. Egg on their faces. The story of human albumin solution. Eval Health Prof 2002; 25(1): 130-138.